Recursion Pharmaceuticals (RXRX) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free RXRX Stock Alerts $8.58 -0.41 (-4.56%) (As of 05/29/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals Stock Price Performance5 Day Performance-5.79%1 Month Performance+5.24%3 Month Performance-35.88%6 Month Performance+22.41%Year-To-Date Performance-12.47%1 Year Performance-3.36% Receive RXRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 RXRX Stock Chart for Wednesday, May, 29, 2024 RXRX Chart by TradingView Recursion Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$9.16$8.99-1.86%$9.62$8.874.57 million shs$2.14 billion05/27/2024$9.16$9.16$9.31$8.973.41 million shs$2.18 billion05/24/2024$9.03$9.16+1.44%$9.31$8.973.41 million shs$2.15 billion05/23/2024$9.36$9.03-3.53%$9.56$8.846.73 million shs$2.12 billion05/22/2024$9.51$9.36-1.58%$9.56$9.223.57 million shs$2.20 billion05/21/2024$9.78$9.51-2.76%$9.80$9.393.02 million shs$2.23 billion Get the Latest News and Ratings for RXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$9.42$9.78+3.82%$9.81$9.253.49 million shs$2.29 billion05/17/2024$9.51$9.42-0.95%$9.58$9.174.72 million shs$2.21 billion05/16/2024$10.01$9.51-5.00%$10.11$9.434.86 million shs$2.23 billion05/15/2024$10.05$10.01-0.40%$10.67$9.686.87 million shs$2.35 billion05/14/2024$9.48$10.05+6.01%$10.56$9.7010.14 million shs$2.36 billion05/13/2024$8.60$9.48+10.23%$10.40$9.0615.37 million shs$2.22 billion05/10/2024$8.64$8.60-0.46%$9.33$8.227.00 million shs$2.02 billion05/09/2024$8.59$8.64+0.58%$8.69$8.462.97 million shs$2.03 billion05/08/2024$8.79$8.59-2.28%$8.77$8.432.55 million shs$2.02 billion05/07/2024$8.94$8.79-1.68%$9.05$8.573.21 million shs$2.06 billion05/06/2024$8.84$8.94+1.13%$9.21$8.823.36 million shs$2.10 billion05/03/2024$8.79$8.84+0.57%$9.40$8.703.93 million shs$2.07 billion05/02/2024$8.34$8.79+5.40%$8.79$8.303.79 million shs$2.06 billion05/01/2024$7.82$8.34+6.65%$8.75$7.735.73 million shs$1.96 billion04/30/2024$8.20$7.82-4.63%$8.26$7.803.84 million shs$1.83 billion04/29/2024$8.12$8.20+0.99%$8.55$8.094.10 million shs$1.92 billion04/26/2024$7.84$8.12+3.57%$8.14$7.684.39 million shs$1.91 billion04/25/2024$7.94$7.84-1.26%$7.89$7.484.31 million shs$1.84 billion04/24/2024$7.70$7.94+3.12%$8.27$7.897.20 million shs$1.86 billion04/23/2024$7.60$7.70+1.32%$7.92$7.554.81 million shs$1.81 billion04/22/2024$7.35$7.60+3.40%$7.79$7.213.94 million shs$1.78 billion04/19/2024$7.40$7.35-0.68%$7.44$7.144.00 million shs$1.72 billion04/18/2024$7.47$7.40-0.94%$7.58$7.272.86 million shs$1.74 billion04/17/2024$7.57$7.47-1.32%$7.71$7.443.51 million shs$1.75 billion04/16/2024$7.79$7.57-2.82%$7.77$7.513.84 million shs$1.78 billion04/15/2024$8.41$7.79-7.37%$8.46$7.775.13 million shs$1.83 billion04/12/2024$8.92$8.41-5.72%$8.93$8.323.43 million shs$1.97 billion04/11/2024$8.58$8.92+3.96%$8.94$8.503.15 million shs$2.09 billion04/10/2024$9.09$8.58-5.61%$8.78$8.413.73 million shs$2.01 billion04/09/2024$9.00$9.09+1.00%$9.22$8.952.57 million shs$2.13 billion04/08/2024$8.87$9.00+1.47%$9.12$8.793.12 million shs$2.11 billion04/05/2024$8.73$8.87+1.60%$8.94$8.413.41 million shs$2.08 billion04/04/2024$8.93$8.73-2.24%$9.33$8.714.72 million shs$2.05 billion04/03/2024$8.77$8.93+1.82%$9.35$8.726.04 million shs$2.10 billionThe only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/02/2024$9.37$8.77-6.40%$9.00$8.676.84 million shs$2.06 billion04/01/2024$9.97$9.37-6.02%$9.98$9.336.48 million shs$2.20 billion03/29/2024$9.97$9.97$10.28$9.945.44 million shs$2.34 billion03/28/2024$10.17$9.97-1.97%$10.28$9.945.18 million shs$2.34 billion03/27/2024$10.32$10.17-1.45%$10.42$10.074.00 million shs$2.39 billion03/26/2024$10.53$10.32-1.99%$10.89$10.315.06 million shs$2.42 billion03/25/2024$10.49$10.53+0.38%$10.91$10.413.82 million shs$2.47 billion03/22/2024$10.65$10.49-1.50%$10.79$10.293.69 million shs$2.46 billion03/21/2024$11.07$10.65-3.79%$11.45$10.268.04 million shs$2.50 billion03/20/2024$10.75$11.07+2.98%$11.18$10.285.41 million shs$2.60 billion03/19/2024$11.42$10.75-5.87%$11.17$10.466.46 million shs$2.52 billion03/18/2024$11.22$11.42+1.78%$12.35$11.1711.34 million shs$2.68 billion03/15/2024$10.78$11.22+4.08%$11.53$10.6111.29 million shs$2.63 billion03/14/2024$10.98$10.78-1.82%$11.87$10.459.97 million shs$2.53 billion03/13/2024$10.54$10.98+4.17%$11.37$10.387.21 million shs$2.58 billion03/12/2024$10.37$10.54+1.64%$10.68$10.164.90 million shs$2.47 billion03/11/2024$11.19$10.37-7.33%$11.55$10.275.54 million shs$2.43 billion03/08/2024$11.15$11.19+0.36%$12.34$10.886.21 million shs$2.42 billion03/07/2024$11.32$11.15-1.50%$11.57$10.746.01 million shs$2.42 billion03/06/2024$11.91$11.32-4.95%$12.13$11.215.20 million shs$2.45 billion03/05/2024$12.30$11.91-3.17%$12.48$11.595.92 million shs$2.58 billion03/04/2024$12.81$12.30-3.98%$12.93$12.056.83 million shs$2.66 billion03/01/2024$13.46$12.81-4.83%$13.62$12.659.14 million shs$2.77 billion02/29/2024$12.94$13.46+4.02%$14.12$13.007.55 million shs$2.92 billion02/28/2024$15.52$12.94-16.62%$14.15$12.5512.98 million shs$2.80 billion Related Companies: ADMA Biologics Stock Chart Kymera Therapeutics Stock Chart Novavax Stock Chart Beam Therapeutics Stock Chart Vericel Stock Chart CG Oncology Stock Chart Immunocore Stock Chart Twist Bioscience Stock Chart Sana Biotechnology Stock Chart Fusion Pharmaceuticals Stock Chart Receive RXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RXRX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star4 Cryptos BETTER than BitcoinTrue Market InsidersMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.